Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study to Determine Protective Efficacy Against Otitis Media and Assess Safety of an Investigational Pneumococcal Vaccine 2189242A in Healthy Infants
Brief Summary: The purpose of this study is to 1) demonstrate the protective efficacy against acute otitis media (AOM), 2) assess safety of the GlaxoSmithKline (GSK) Biologicals' pneumococcal vaccine GSK2189242A in Native American infants aged less than 24 months, living in the southwestern US, in and around the Navajo and White Mountain Apache reservations, and 3) evaluate the impact on acute lower respiratory tract infections (ALRI) up to the second year of life.


Options:
A: Arm Label: 10Pn3+1-6W- 6M/043 Group; Type: EXPERIMENTAL; Interventions: Biological: Pneumococcal conjugate vaccine GSK1024850A | Arm Label: 10Pn2+1-6W-6M/043 Group; Type: EXPERIMENTAL; Interventions: Biological: Pneumococcal conjugate vaccine GSK1024850A | Arm Label: Ctrl-6W-6M/043 Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: GSK Biologicals' Engerix TM vaccine (Hepatitis B vaccine) | Arm Label: 10Pn7-11M/043 Group; Type: EXPERIMENTAL; Interventions: Biological: Pneumococcal conjugate vaccine GSK1024850A | Arm Label: Ctrl7-11M/043 Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: GSK Biologicals' Engerix TM vaccine (Hepatitis B vaccine) | Arm Label: 10Pn12-18M/043 Group; Type: EXPERIMENTAL; Interventions: Biological: Pneumococcal conjugate vaccine GSK1024850A | Arm Label: Ctrl12-18M/043 Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: GSK Biologicals' Havrix TM vaccine (Hepatitis A vaccine) | Intervention Type: BIOLOGICAL; Name: Pneumococcal conjugate vaccine GSK1024850A; Assigned to Arm(s): 10Pn12-18M/043 Group, 10Pn2+1-6W-6M/043 Group, 10Pn3+1-6W- 6M/043 Group, 10Pn7-11M/043 Group | Intervention Type: BIOLOGICAL; Name: GSK Biologicals' Engerix TM vaccine (Hepatitis B vaccine); Assigned to Arm(s): Ctrl-6W-6M/043 Group, Ctrl7-11M/043 Group | Intervention Type: BIOLOGICAL; Name: GSK Biologicals' Havrix TM vaccine (Hepatitis A vaccine); Assigned to Arm(s): Ctrl12-18M/043 Group
B: Arm Label: Synflorix Group; Type: EXPERIMENTAL; Interventions: Biological: Pneumococcal conjugate vaccine GSK1024850A, Biological: Havrix, Biological: Infanrix hexa, Biological: GSK Biologicals' DTPa-IPV/Hib vaccine | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: Havrix, Biological: Engerix-B, Biological: GSK Biologicals' DTPa-IPV/Hib vaccine | Intervention Type: BIOLOGICAL; Name: Pneumococcal conjugate vaccine GSK1024850A; Assigned to Arm(s): Synflorix Group | Intervention Type: BIOLOGICAL; Name: Havrix; Assigned to Arm(s): Control Group, Synflorix Group | Intervention Type: BIOLOGICAL; Name: Engerix-B; Assigned to Arm(s): Control Group | Intervention Type: BIOLOGICAL; Name: Infanrix hexa; Assigned to Arm(s): Synflorix Group | Intervention Type: BIOLOGICAL; Name: GSK Biologicals' DTPa-IPV/Hib vaccine; Assigned to Arm(s): Control Group, Synflorix Group
C: Arm Label: dPly-PhtD Group; Type: EXPERIMENTAL; Interventions: Biological: Pneumococcal vaccine GSK2189242A, Biological: Prevnar 13®, Biological: PedvaxHIB® | Arm Label: Control Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo, Biological: Prevnar 13®, Biological: PedvaxHIB® | Intervention Type: BIOLOGICAL; Name: Pneumococcal vaccine GSK2189242A; Assigned to Arm(s): dPly-PhtD Group | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Control Group | Intervention Type: BIOLOGICAL; Name: Prevnar 13®; Assigned to Arm(s): Control Group, dPly-PhtD Group | Intervention Type: BIOLOGICAL; Name: PedvaxHIB®; Assigned to Arm(s): Control Group, dPly-PhtD Group
D: Arm Label: Synflorix + Infanrix hexa Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: GSK Biologicals´ Pneumococcal Conjugate Vaccine GSK1024850A (Synflorix™), Biological: Infanrix™ hexa. | Arm Label: Synflorix + Pediacel Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals´ Pneumococcal Conjugate Vaccine GSK1024850A (Synflorix™), Biological: Pediacel™ | Arm Label: Prevenar + Pediacel Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: Pediacel™, Biological: Prevenar™ | Intervention Type: BIOLOGICAL; Name: GSK Biologicals´ Pneumococcal Conjugate Vaccine GSK1024850A (Synflorix™); Assigned to Arm(s): Synflorix + Infanrix hexa Group, Synflorix + Pediacel Group | Intervention Type: BIOLOGICAL; Name: Infanrix™ hexa.; Assigned to Arm(s): Synflorix + Infanrix hexa Group | Intervention Type: BIOLOGICAL; Name: Pediacel™; Assigned to Arm(s): Prevenar + Pediacel Group, Synflorix + Pediacel Group | Intervention Type: BIOLOGICAL; Name: Prevenar™; Assigned to Arm(s): Prevenar + Pediacel Group

Answer: C